Corporate Banner
Satellite Banner
Technology Networks Header
Monday, September 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Agilent Introduces Higher-Performance Q-TOF GC/MS System
Thursday, September 04, 2014
Company introduces 7200B system, featuring optimized hardware/software capabilities.

Thermo Scientific Teams with NRLs on New European Regulation
Wednesday, September 03, 2014
Allowing GC-MS/MS to confirm dioxins in feed and food.

Impressive Separation of a Fusion Protein
Friday, August 29, 2014
Separation of protein by high-resolution hydrophobic interaction chromatography method.

Elegant Fraction Collection Storage Solution
Wednesday, August 27, 2014
Company offers a free pack of 50 cap mats with each order until 30th November 2014.

Waters Launches Progenesis QI Version 2.0 for Small Molecule Data Analysis at IMSC 2014
Monday, August 25, 2014
Next Generation Software Offers Enhanced Control and Function, with Pathway Mapping, Process Automation, and Improved Access to Compound Databases.

Shimadzu Announces New i-Series Integrated Liquid Chromatography Systems
Thursday, August 21, 2014
Innovative, intuitive and intelligent functionality advances HPLC for labs of the future.

New Hydrophobic Interaction Column from Thermo Fisher Scientific
Wednesday, August 20, 2014
Laboratories are offered additional selectivity for separating monoclonal antibodies or antibody-drug conjugates.

Simple and Accurate Determination of Total Choline
Friday, August 08, 2014
Total choline determination in infant formulas and adult nutritionals by ion chromatography method.

Determination of Thiosulfate and Pyrophosphate in Crayfish Wash Powder
Tuesday, August 05, 2014
Determination by a simple, efficient, sensitive, and reproducible capillary ion chromatography method.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 772
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv